![Ruo Yu Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruo Yu Chen
Directeur/Membre du Conseil chez
Continent Pharmaceutical Inc.
Fortune : - $ au 31/05/2026
Profil
Ruo Yu Chen currently works at Continent Pharmaceutical, Inc., as Executive Director from 2018, Beijing Continent Pharmaceutical Co., Ltd., as Executive Director from 2018, GNI-EPS Pharmaceuticals, inc., as Supervisor, Cullgen, Inc., as Finance Controller, and Cullgen Shanghai, Inc., as Supervisor.
Ms. Chen also formerly worked at GNI Group Ltd., as Director-Finance & Accounting from 2014 to 2021, GNI USA, Inc., as Senior Vice President-Finance, Protiviti LLC, as Manager-Internal Audit Division from 2011 to 2014, and Gyre Therapeutics, Inc., as Chief Financial Officer from 2023 to 2026.
Ms. Chen received her undergraduate degree in 1992 from Nankai University and graduate degree from Graduate School of Economics Kyoto University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Ruo Yu Chen
| Sociétés | Poste | Début |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Directeur/Membre du Conseil | 18/07/2018 |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Comptroller/Controller/Auditor | - |
Cullgen Shanghai, Inc. | Directeur/Membre du Conseil | - |
GNI-EPS Pharmaceuticals, inc. | Directeur/Membre du Conseil | - |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells biological technology medicines | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Ruo Yu Chen
| Sociétés | Poste | Fin |
|---|---|---|
| GNI GROUP LTD. | Comptroller/Controller/Auditor | 01/01/2021 |
Protiviti LLC
 Protiviti LLC Miscellaneous Commercial ServicesCommercial Services Provides independent risk consulting and internal audit services | Comptroller/Controller/Auditor | 01/01/2014 |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Corporate Officer/Principal | - |
Formation de Ruo Yu Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GNI Group Ltd.
 GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Health Technology |
GNI-EPS Pharmaceuticals, inc. | |
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Graduate School of Economics Kyoto University
 Graduate School of Economics Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protiviti LLC
Protiviti LLC Miscellaneous Commercial ServicesCommercial Services Provides independent risk consulting and internal audit services | Commercial Services |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells biological technology medicines | Health Technology |
Cullgen Shanghai, Inc. |
